In this study, we used a nationally representative sample of U.S. adults to investigate the association between NAFLD and CKM progression, as well as its impact on all-cause and cardiovascular mortality, offering new insights into the role of NAFLD within the CKM framework. The gene discussed is CKM; the disease is metabolic dysfunction-associated steatotic liver disease.